◂ Announcements

Apr 15, 2026ACQUISITIONRouen, France, France

Stereotaxis to acquire Robocath

Stereotaxis has entered into a definitive agreement to acquire Robocath, a venture-backed innovator of robotic technologies for interventional cardiology and neurointerventions. The acquisition strengthens Stereotaxis' position in endovascular procedures.

Value

$45.0M

Status

Announced

Productssurgical robotics for endovascular interventionR-One+ robotic system for percutaneous coronary interventions

CompaniesRobocath target Stereotaxis acquirer

Sectors#Automation and Robotics #Medical Devices

“Robocath represents a highly strategic addition to Stereotaxis, amplifying and accelerating our strategy as the leading robotic platform for the broad spectrum of endovascular procedures.”stereotaxis.gcs-web.com

2 sources
stereotaxis.gcs-web.comStereotaxis Announces Definitive Agreement to Acquire Robocath | Stereotaxis Inc.Apr 15, 2026
medicaldevice-network.comStereotaxis to acquire Robocath for up to $45mSalong DebbarmaApr 16, 2026

Summarized from public sources; check the original articles before acting on it.

More from Robocath

profile ▸

Loading…